Laurent Givalois
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Intranasal lipid nanocapsule administration of the new lipophenol quercetin-3-O-DHA-7-O-iPr reduces carbonyl stress and improves behavior in a mouse model of Alzheimer's disease.
Journal: Drug delivery and translational research
Published: December 10, 2025
Neurophysiological and neuroinflammatory adaptations to seizure activity in aging.
Journal: Neurobiology of disease
Published: July 23, 2025
A photoswitchable positive allosteric modulator to control the activation of the metabotropic glutamate receptor 5 by light.
Journal: Biochemical pharmacology
Published: January 13, 2025
Nose-to-brain delivery of DHA-loaded nanoemulsions: A promising approach against Alzheimer's disease.
Journal: International journal of pharmaceutics
Published: October 16, 2024
Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models.
Journal: British journal of pharmacology
Published: August 27, 2024
Bursts of brain erosion: seizures and age-dependent neurological vulnerability.
Journal: Trends in molecular medicine
Published: August 20, 2024
Overview of alkyl quercetin lipophenol synthesis and its protective effect against carbonyl stress involved in neurodegeneration.
Journal: Organic & biomolecular chemistry
Published: March 25, 2024
Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.
Journal: Journal of medicinal chemistry
Published: October 05, 2023
Hormone profiles of the African pygmy mouse Mus minutoides, a species with XY female sex reversal.
Journal: Journal of experimental zoology. Part A, Ecological and integrative physiology
Published: July 26, 2023
The pathomimetic oAβ25-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents.
Journal: Pharmacology & therapeutics
Published: March 22, 2023
Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer's Disease.
Journal: Antioxidants (Basel, Switzerland)
Published: March 01, 2022
Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways.
Journal: Epilepsia
Published: November 26, 2021
Last Updated: 09/26/2026